Skip to content

Care for common mental disorders in Tuberculosis Services in India A Randomized Controlled Feasibility Trial.

Integrating Care For Depression, Anxiety and Substance Abuse in Tuberculosis Services in India A Randomized Controlled Feasibility Trial. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086905
Enrollment
36
Registered
2025-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung Health Condition 2: F320- Major depressive disorder, singleepisode, mild Health Condition 3: F321- Major depressive disorder, singleepisode, moderate Health Condition 4: F411- Generalized anxiety disorder Health Condition 5: F102- Alcohol dependence Health Condition 6: F172- Nicotine dependence

Interventions

Intervention1: In the intervention arm, the participants will receive up to six face to face sessions of behavioural support intervention which will include Behavioural activation(BA) for depression,

Sponsors

Dr Krishna Prasad M
Lead Sponsor
Dr Geetha Desai
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or over. 2. Diagnosed with Tuberculosis (Pulmonary and Extra Pulmonary TB) 3.Current diagnosis of depression, anxiety and problematic alcohol and tobacco use(confirmed with clinician administered PHQ-9 and or GAD-7 Score of more than 10, smoking status and willing to quit. 4.TB patients with comorbidities such as diabetes, HIV will not be excluded. 5. Willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Already receiving psychotherapy and/or medications for depression/anxiety/ substance use. 2. Lacking capacity to provide informed consent. 3. Unable to take part in therapy because of cognitive impairment, developmental disorders or severity of mental or physical illness. 4. Patients with drug resistant TB

Design outcomes

Primary

MeasureTime frame
Acceptability, feasibility and implementation of the TB-MH intervention. Also, the feasibility trial will inform the development of a full trial RCT protocolTimepoint: Data will be collected at baseline, endline, 1 month, 3 months and 6 months.

Secondary

MeasureTime frame
Recruitment rates, retention rates in the study, retention rates in the intervention group, and data completenessTimepoint: Data will be collected at baseline, endline, 1 month, 3 months and 6 months.

Countries

India

Contacts

Public ContactDr Krishna Prasad M

NIMHANS

krishnadoc2004@gmail.com9902648496

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026